⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANVS News
Annovis Bio, Inc.
Form 8-K
sec.gov
ANVS
Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results
globenewswire.com
ANVS
Annovis CEO to Present on Multi-Protein Model of Alzheimer's Disease at Fierce Biotech Week 2026
globenewswire.com
ANVS
Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio
globenewswire.com
ANVS
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
globenewswire.com
ANVS
Form 8-K
sec.gov
ANVS
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants
globenewswire.com
ANVS
The Credibility Filter Wall Street Uses to Sort Biotech Winners
globenewswire.com
ARQT
ANVS
STOK
NTLA
Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
globenewswire.com
ANVS
Annovis Publishes Historical Review of Buntanetap in The Scientist
globenewswire.com
ANVS